Cathie Wood Is Buying Up Alamar Biosciences Stock After Its IPO. Should You Snag Proteomics-Focused ALMR Too?
While Cathie Wood’s involvement adds visibility, market sentiment remains mixed on whether ALMR offers sustainable upside at current valuation levels.
Precision Proteomics Leader Alamar Biosciences Lists on NASDAQ
SHANGHAI , April 20, 2026 /PRNewswire/ -- Alamar Biosciences, a portfolio company of Qiming Venture Partners and a global leader in precision proteomics, successfully listed on the NASDAQ Stock Exchange...